Alliance Pharma announces Camillo Pane to its Board of Directors as new Chair

– UK, Chippenham –  Alliance Pharma plc (LON: APH), the international healthcare group, today announced the appointment of Camillo Pane to its Board of Directors as Chair effective on 19 February 2024, to succeed Jo LeCouilliard who is stepping down from the Board.

“We look forward to Camillo joining the Board as Chair and harnessing his wide-ranging consumer healthcare experience to further enhance and develop our Group strategy. In the meantime, the Board remains focused on creating value for our shareholders by investing in growth whilst carefully managing our cost base.” said Senior Independent Director, Richard Jones.

About Camillo Pane

Camillo Pane has over thirty years of experience in US, European, and Asian public, multinational Consumer companies. During his career, Camillo has held many senior positions at Reckitt Benckiser where he spent almost 20 years across both Global and Regional roles, including SVP and Global Category Officer for Consumer Health, before moving to Coty Inc., one of the largest beauty companies in the world, where, as CEO, he led the merger with Procter & Gamble Specialty Beauty.

Most recently, he was Group CEO of Health & Happiness Group, a global Health and Nutrition company listed on the Hong Kong Stock Exchange with revenues of around $2bn.

About Alliance

Alliance Pharma plc is a growing consumer healthcare company. Our purpose is to empower people to make a positive difference in their health and wellbeing by making our trusted and proven brands available around the world.

We deliver organic growth through investing in our priority brands and channels, in related innovation, and through selective geographic expansion to increase the reach of our brands. Periodically, we may look to enhance our organic growth through selective, complementary acquisitions.

Headquartered in the UK, the Group employs around 285 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics we remain asset-light and focused on maximizing the value we can bring, both to our stakeholders and to our brands.

SOURCE: https://www.alliancepharmaceuticals.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.